TPI
AQST icon

Trust Point Inc’s Aquestive Therapeutics AQST Stock Holding History

Trust Point Inc’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,048
Closed -$129K – 489
2026
Q1 		$129K Buy
31,048
+7,000
+29% +$28.4K 0.01% 514
2025
Q4 		$155K Buy
24,048
+1,595
+7% +$9.94K 0.01% 475
2025
Q3 		$126K Buy
+22,453
New +$97.1K 0.01% 476
2025
Q2 		– Sell
-23,396
Closed -$67.8K – 409
2025
Q1 		$67.8K Buy
23,396
+9,625
+70% +$29.1K 0.01% 456
2024
Q4 		$49K Hold
13,771
– – ﹤0.01% 559
2024
Q3 		$68.6K Hold
13,771
– – 0.01% 513
2024
Q2 		$35.8K Hold
13,771
– – ﹤0.01% 494
2024
Q1 		$58.7K Buy
13,771
+3,726
+37% +$12.4K ﹤0.01% 523
2023
Q4 		$20.3K Buy
+10,045
New +$17.8K ﹤0.01% 495

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Trust Point Inc's AQST Position: Q2 2026 in Review

Trust Point Inc sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 31,048 shares — an estimated $129K sold.

Trust Point Inc first reported a position in AQST in Q4 2023 and held it in 9 quarters. The position peaked at $155K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Trust Point Inc reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 31,048 Aquestive Therapeutics shares in Q2 2026, an estimated $129K.
  • Trust Point Inc first reported a position in Aquestive Therapeutics in Q4 2023 and held it in 9 quarters.
  • Trust Point Inc's Aquestive Therapeutics position peaked at $155K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.